Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer
Phase 3
- Conditions
- Response to ToxinToxicityRecurrence
- Interventions
- Drug: Two-week course of radiation
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Jong Hoon Lee
- Target Recruit Count
- 370
- Registration Number
- NCT02484040
- Locations
- 🇰🇷
Lee Jong Hoon, Suwon, Korea, Republic of
3DCRT vs. IMRT in Early Breast Cancer
Phase 3
- Conditions
- Radiation Toxicity
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Jong Hoon Lee
- Target Recruit Count
- 690
- Registration Number
- NCT02440191
- Locations
- 🇰🇷
St. Vincent Hospital, Suwon, Korea, Republic of
Short-course Preoperative Chemoradiotherapy for Rectal Cancer
Phase 2
- Conditions
- Rectal Cancer
- First Posted Date
- 2011-09-09
- Last Posted Date
- 2017-10-10
- Lead Sponsor
- Jong Hoon Lee
- Target Recruit Count
- 80
- Registration Number
- NCT01431599
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
News
No news found